Multiple sclerosis (MS) is a neurological disease that affects about 1 million people in the United States. Your brain contains a type of cell called a neuron, and neurons are coated in a layer of ...

The drug appears effective against both “relapsing” and “primary progressive” forms of the disease, though some analysts ...

Join the School of Medicine’s Department of Population and Quantitative Health Sciences to learn about the options available with an MS in clinical research. A webinar will be held Sunday, Dec. 20, at ...

Researchers have developed a new and unique blood test to measure the immune response to the Epstein Barr Virus (EBV) which is the leading risk factor for developing multiple sclerosis (MS). Their ...

A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

Newcastle's Professor Jeannette Lechner-Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even ...

The Combined Bachelor’s/Master’s Degree program (CBM) is intended for highly motivated current CWRU undergraduate students who are candidates for any bachelor's ...

The Clinical Research Management (CRM) specialty track provides the education and training needed to manage clinical trials research, including knowledge needed to ensure that clinical trials adhere ...